79 related articles for article (PubMed ID: 8815025)
1. [Mechanisms of action of high-dosage glucocorticoid therapy].
Buttgereit F; Dimmeler S; Neugebauer E; Burmester GR
Dtsch Med Wochenschr; 1996 Feb; 121(8):248-52. PubMed ID: 8815025
[No Abstract] [Full Text] [Related]
2. Genomic and nongenomic effects of glucocorticoids.
Stahn C; Buttgereit F
Nat Clin Pract Rheumatol; 2008 Oct; 4(10):525-33. PubMed ID: 18762788
[TBL] [Abstract][Full Text] [Related]
3. [On genomic and nongenomic effects. Molecular basis of glucocorticoid action].
Eberhardt W; Kilz T
Pharm Unserer Zeit; 2003; 32(4):288-94. PubMed ID: 12899065
[No Abstract] [Full Text] [Related]
4. Glucocorticoids: mechanisms of action and anti-inflammatory potential in asthma.
van der Velden VH
Mediators Inflamm; 1998; 7(4):229-37. PubMed ID: 9792333
[TBL] [Abstract][Full Text] [Related]
5. The effects of non-genomic glucocorticoid mechanisms on bodily functions and the central neural system. A critical evaluation of findings.
Haller J; Mikics E; Makara GB
Front Neuroendocrinol; 2008 May; 29(2):273-91. PubMed ID: 18054070
[TBL] [Abstract][Full Text] [Related]
6. Update on glucocorticoid action and resistance.
Ito K; Chung KF; Adcock IM
J Allergy Clin Immunol; 2006 Mar; 117(3):522-43. PubMed ID: 16522450
[TBL] [Abstract][Full Text] [Related]
7. Molecular mechanisms of glucocorticoid action and selective glucocorticoid receptor agonists.
Stahn C; Löwenberg M; Hommes DW; Buttgereit F
Mol Cell Endocrinol; 2007 Sep; 275(1-2):71-8. PubMed ID: 17630118
[TBL] [Abstract][Full Text] [Related]
8. Molecular mechanisms of glucocorticoid resistance/hypersensitivity. Potential clinical implications.
Chrousos GP; Castro M; Leung DY; Webster E; Kino T; Bamberger C; Elliot S; Stratakis C; Karl M
Am J Respir Crit Care Med; 1996 Aug; 154(2 Pt 2):S39-43; discussion S43-4. PubMed ID: 8756786
[No Abstract] [Full Text] [Related]
9. Pharmacology of glucocorticoids: beyond receptors.
van der Laan S; Meijer OC
Eur J Pharmacol; 2008 May; 585(2-3):483-91. PubMed ID: 18410913
[TBL] [Abstract][Full Text] [Related]
10. Molecular and functional evidence for in vitro cytokine enhancement of human and murine target cell sensitivity to glucocorticoids. TNF-alpha priming increases glucocorticoid inhibition of TNF-alpha-induced cytotoxicity/apoptosis.
Costas M; Trapp T; Pereda MP; Sauer J; Rupprecht R; Nahmod VE; Reul JM; Holsboer F; Arzt E
J Clin Invest; 1996 Sep; 98(6):1409-16. PubMed ID: 8823306
[TBL] [Abstract][Full Text] [Related]
11. The molecular complexity of glucocorticoid actions in inflammation - a four-ring circus.
Goulding NJ
Curr Opin Pharmacol; 2004 Dec; 4(6):629-36. PubMed ID: 15525555
[TBL] [Abstract][Full Text] [Related]
12. Mechanism of glucocorticoid action.
Gower WR
J Fla Med Assoc; 1993 Oct; 80(10):697-700. PubMed ID: 8270904
[TBL] [Abstract][Full Text] [Related]
13. Corticosteroid therapy in asthma: predictors of responsiveness.
Mjaanes CM; Whelan GJ; Szefler SJ
Clin Chest Med; 2006 Mar; 27(1):119-32, vii. PubMed ID: 16543057
[TBL] [Abstract][Full Text] [Related]
14. Effects of glucocorticoids on endogenous and transcellular metabolism of eicosanoids in asthma.
Vachier I; Chavis C; Majori M; Farce M; Bousquet J; Godard P; Chanez P
J Allergy Clin Immunol; 2001 May; 107(5):824-31. PubMed ID: 11344349
[TBL] [Abstract][Full Text] [Related]
15. [Molecular mechanisms of glucocorticoid action].
Kyrge PK
Usp Fiziol Nauk; 1981; 12(1):56-79. PubMed ID: 7013320
[No Abstract] [Full Text] [Related]
16. Proinflammatory cytokines regulate human glucocorticoid receptor gene expression and lead to the accumulation of the dominant negative beta isoform: a mechanism for the generation of glucocorticoid resistance.
Webster JC; Oakley RH; Jewell CM; Cidlowski JA
Proc Natl Acad Sci U S A; 2001 Jun; 98(12):6865-70. PubMed ID: 11381138
[TBL] [Abstract][Full Text] [Related]
17. [Mechanisms of the anti-inflammatory action of glucocorticoids].
Belovezhdov N
Vutr Boles; 1985; 24(6):1-5. PubMed ID: 3913140
[No Abstract] [Full Text] [Related]
18. Selective glucocorticoid receptor agonists (SEGRAs): novel ligands with an improved therapeutic index.
Schäcke H; Berger M; Rehwinkel H; Asadullah K
Mol Cell Endocrinol; 2007 Sep; 275(1-2):109-17. PubMed ID: 17630119
[TBL] [Abstract][Full Text] [Related]
19. Characterization of selective glucocorticoid-dependent responses in a glucocorticoid-resistant smooth muscle tumor cell line.
Fan W; Cooper TM; Norris JS
J Cell Physiol; 1993 Jul; 156(1):88-95. PubMed ID: 8314862
[TBL] [Abstract][Full Text] [Related]
20. [Glucocorticoid-induced insulin resistance and diabetes mellitus. Receptor-, postreceptor mechanisms, local cortisol action, and new aspects of antidiabetic therapy].
Meyer G; Badenhoop K
Med Klin (Munich); 2003 Apr; 98(5):266-70. PubMed ID: 12721671
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
